Laekna Therapeutics
China - ShanghaiBiotechnology
Focus: Laekna Therapeutics is a Shanghai-based biotech company developing small-molecule oncology and gastroenterology therapeutics, currently in early-to-mid stage clinical development with a public listing status.
Profile data last refreshed 2d ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Laekna Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Laekna Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
LAE005 + Afuresertib + Nab-Paclitaxel
Solid TumorClinical Trials (1)
NCT05390710PhI to Solid Tumors and PhII to Locally Advanced or mTNBC
Phase 1Help build intelligence for Laekna Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.